Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/88083
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Martínez Gil, Ana | - |
dc.contributor.author | Gil, Carmen | - |
dc.contributor.author | Castro, Ana | - |
dc.contributor.author | Pérez, Concepción | - |
dc.contributor.author | Prieto, Carlos | - |
dc.contributor.author | Otero, Joaquín | - |
dc.date.accessioned | 2013-12-03T11:29:39Z | - |
dc.date.available | 2013-12-03T11:29:39Z | - |
dc.date.issued | 2003 | - |
dc.identifier | doi: 10.1016/S0968-0896(03)00148-2 | - |
dc.identifier | issn: 0968-0896 | - |
dc.identifier | e-issn: 1464-3391 | - |
dc.identifier.citation | Bioorganic and Medicinal Chemistry 11: 2395- 2402 (2003) | - |
dc.identifier.uri | http://hdl.handle.net/10261/88083 | - |
dc.description.abstract | Two new series of BTD derivatives have been synthesised allowing to explore the steric requirements for their biological activity. The N3-alkylBTD compounds have shown antiviral activity in the same order or lower than previously prepared compounds. However, the cytotoxicity values observed prevent this new series of BTD derivatives from its potential therapeutic application. Concerning BTD derivatives with the modified linker attached to N1 position, we have obtained new non-nucleoside anti-HCMV derivatives. The activity against HCMV is shown at concentrations that were 10-fold lower than the concentration that was toxic for the host cells, which confirm that these derivatives show a specific antiviral effect against HCMV. SAR conclusions derived from these last compounds have provided new knowledge about the structural requirements of BTD showing certain positions that could be modified for enhancing the anti-HCMV action. © 2003 Elsevier Science Ltd. All rights reserved. | - |
dc.language.iso | eng | - |
dc.publisher | Pergamon Press | - |
dc.rights | closedAccess | - |
dc.title | Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. Study of structural requirements for biological activity | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1016/S0968-0896(03)00148-2 | - |
dc.date.updated | 2013-12-03T11:29:40Z | - |
dc.description.version | Peer Reviewed | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.fulltext | No Fulltext | - |
item.openairetype | artículo | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
8
checked on 07-mar-2024
WEB OF SCIENCETM
Citations
5
checked on 29-feb-2024
Page view(s)
383
checked on 18-mar-2024
Download(s)
113
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.